Topics

CARMAT secures FDA conditional approval for total artificial heart study

16:21 EDT 13 Sep 2019 | Compelo Medical Devices

CARMAT announced that the US Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (IDE) application for the Early Feasibility Study (EFS) of its total

The post CARMAT secures FDA conditional approval for total artificial heart study appeared first on NS Medical Devices.

Original Article: CARMAT secures FDA conditional approval for total artificial heart study

NEXT ARTICLE

More From BioPortfolio on "CARMAT secures FDA conditional approval for total artificial heart study"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...